Spectral AI receives UKCA authorization for burn wound diagnosis; expects H2 2024 revenue

Spectral AI, Inc.

DeepView AI®-Burn obtained UKCA authorization for aiding burn wound diagnosis in the United Kingdom.
Company expects to deploy six devices in the UK for customer evaluation and start generating revenue in H2 2024.
This revenue adds to previously communicated $28 million revenue guidance for 2024.
Technology claims 92% accuracy in distinguishing healing vs. non-healing tissue vs. 50-75% for clinical observation.
UKCA authorization also opens expansion into regions like the Middle East that recognize the mark.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.